| Sorafenib in Hepatocellular Carcinoma Clinical Practice in Italy (NCT01539681) | Bayer | 2012-02-01 |
| A Phase Ib Study of Stereotactic Body Radiotherapy (SBRT) Plus Sorafenib in Patients With Unresectable Hepatocellular Carcinoma (HCC) (NCT01801163) | Indiana University | 2012-02-01 |
| Chemoembolization for Hepatocellular Carcinoma (NCT02821533) | Chinese University of Hong Kong | 2012-02-01 |
| Neoadjuvant Sorafenib Therapy Prior to Laser Ablation for Hepatocellular Carcinoma (NCT01507064) | Cardarelli Hospital | 2012-01-01 |
| The Effect of Vitamin D Repletion in Patients With Hepatocellular Carcinoma on the Orthotopic Liver Transplant List (NCT01575717) | Andrea Branch | 2012-01-01 |
| Recurrence of Hepatocellular Carcinoma (NCT01520779) | Ain Shams University | 2012-01-01 |
| Combine TACE and RFA Versus RFA Monotherapy in Unilobar HCC of 3.1 to 7 cm Patient (NCT01858207) | Shi-Ming Lin | 2012-01-01 |
| Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma (NCT01850667) | Korea Cancer Center Hospital | 2012-01-01 |
| Evaluation of Proteasome as a Marker of Hepatocellular Carcinoma in Cirrhotic Patients Following Curative Treatment (NCT01492127) | University Hospital, Montpellier | 2011-12-01 |
| The LC Bead Trial; Transarterial Chemoembolization of Hepatocellular Carcinoma (HCC)With a Drug-eluting Bead (NCT01259024) | Washington University School of Medicine | 2011-12-01 |
| Palliative Treatment of Hepatocellular Carcinoma in Patient With CHILD B Cirrhosis (NCT01357486) | University Hospital, Bordeaux | 2011-11-14 |
| Radiofrequency Ablation Using Octopus Electrodes for Treatment of Focal Liver Malignancies: Follow-up Study (NCT02745483) | Seoul National University Hospital | 2011-11-01 |
| Radiofrequency Ablation Using Octopus Electrodes for Treatment of Focal Liver Malignancies (NCT02683538) | Seoul National University Hospital | 2011-11-01 |
| Caphosol in Oral Mucositis Due to Targeted Therapy (NCT01265810) | Impaqtt Foundation | 2011-11-01 |
| Percutaneous Radiofrequency Ablation Versus Repeat Hepatectomy for Recurrent Hepatocellular Carcinoma (NCT01570166) | Sun Yat-sen University | 2011-11-01 |
| RCT on Adjuvant TACE After Hepatectomy for HCC (NCT01512407) | Chinese University of Hong Kong | 2011-11-01 |
| Radiofrequency Ablation Versus Liver Resection for Elderly Patients With Hepatocellular Carcinoma (HCC) Within the Milan Criteria (NCT01570075) | Sun Yat-sen University | 2011-11-01 |
| S-1/LV One Week on and One Week Off Regimen in Advanced Hepatocellular Carcinoma (HCC) (NCT01533324) | Second Military Medical University | 2011-11-01 |
| A Phase 2b Study of Modified Vaccinia Virus to Treat Patients Advanced Liver Cancer Who Failed Sorafenib (NCT01387555) | Jennerex Biotherapeutics | 2011-10-08 |
| Efficacy of Radiation Therapy and Transarterial Chemoembolization (TACE) to Treat Hepatocellular Carcinoma (HCC) (NCT01432314) | Asan Medical Center | 2011-10-01 |
| Magnetic Resonance Elastography (MRE) as a Predictor of HCC Recurrence After Radiofrequency Ablation (RFA) (NCT01447667) | Seoul National University Hospital | 2011-10-01 |
| PROLIFICA - West African Treatment Cohort for Hepatitis B (NCT02129829) | Imperial College London | 2011-10-01 |
| Prediction of Liver-related Outcomes After HCV Cure (NCT04460157) | Hospital Universitario de Valme | 2011-10-01 |
| A Study of Adoptive Immunotherapy With Autologous Tumor Infiltrating Lymphocytes in Solid Tumors (NCT01462903) | Sun Yat-sen University | 2011-09-01 |
| Transarterial RAdioembolization Versus ChemoEmbolization for the Treatment of Hepatocellular Carcinoma (HCC) (NCT01381211) | University Hospital, Ghent | 2011-09-01 |
| A Phase III PI-88 in the Adjuvant Treatment of Subjects With Hepatitis Virus Related HCC After Surgical Resection (NCT01402908) | Cellxpert Biotechnology Corp. | 2011-08-01 |
| PLA for HCC and Esophageal ca Serum (NCT01957241) | National Taiwan University Hospital | 2011-08-01 |
| Carbon Ion Radiotherapy for Hepatocellular Carcinoma (NCT01167374) | University Hospital Heidelberg | 2011-08-01 |
| TACE as an Adjuvant Therapy After Hepatectomy for HCC (NCT01966133) | Jia Fan | 2011-08-01 |
| E7050 in Combination With Sorafenib Versus Sorafenib Alone as First Line Therapy in Participants With Hepatocellular Carcinoma (NCT01271504) | Eisai Inc. | 2011-07-19 |
| A Study of Dovitinib Versus Sorafenib in Adult Patients With Hepatocellular Carcinoma (HCC) as a First Line Treatment (NCT01232296) | Novartis Pharmaceuticals | 2011-07-01 |
| Phase I/II Study of OPB-31121 in Patients With Progressive Hepatocellular Carcinoma (NCT01406574) | Otsuka Pharmaceutical Co., Ltd. | 2011-07-01 |
| Study of Tyroserleutide for Injection in Hepatocellular Carcinoma (HCC) Patients (NCT01489566) | Shenzhen Kangzhe Pharmaceutical Co., Ltd. | 2011-07-01 |
| Ph 3 ADI-PEG 20 Versus Placebo in Subjects With Advanced Hepatocellular Carcinoma Who Have Failed Prior Systemic Therapy (NCT01287585) | Polaris Group | 2011-07-01 |
| Safety and Efficacy of Oncoxin in Hepatocellular Carcinoma (HCC) (NCT01392131) | Clinical Research Organization, Dhaka, Bangladesh | 2011-07-01 |
| TRC105 for Liver Cancer That Has Not Responded to Sorafenib (NCT01375569) | National Cancer Institute (NCI) | 2011-06-22 |
| Association of Conformational High-dose Radiotherapy and of Hyperselective Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma (NCT01300143) | Nantes University Hospital | 2011-06-01 |
| Safety and Efficacy of RAD001 + TACE in Localized Unresectable HCC (NCT01379521) | Novartis Pharmaceuticals | 2011-06-01 |
| HepaSphere/Quadrasphere Microspheres for Delivery of Doxorubicin for the Treatment of Hepatocellular Cancer (NCT01387932) | Merit Medical Systems, Inc. | 2011-06-01 |
| Evaluation of 11 C-Choline PET-CT for Detection of Hepatocellular Carcinoma (NCT01377220) | Commissariat A L'energie Atomique | 2011-06-01 |
| Hepatocellular Carcinoma (HCC) Transarterial Chemoembolisation (TACE) +Axitinib (NCT01352728) | Chinese University of Hong Kong | 2011-05-18 |
| Effect of Sorafenib or Regorafenib on P63 Expression and Keratinocyte Differentiation in Human Skin (NCT01466504) | Dartmouth-Hitchcock Medical Center | 2011-05-01 |
| Evaluation of Cirrhosis and Malignant Hepatic Lesions Using Novel MR Contrast Agents (NCT01341132) | San Francisco Veterans Affairs Medical Center | 2011-05-01 |
| Lenalidomide in Combination With a Fixed Dose of Sorafenib for the Treatment of Hepatocellular Carcinoma (NCT01348503) | Indiana University | 2011-05-01 |
| Drug-eluting Bead in Hepatocellular Carcinoma (NCT01332669) | Seoul National University Hospital | 2011-04-01 |
| Temsirolimus + Sorafenib in Advanced Hepatocellular Carcinoma (HCC) (NCT01335074) | Philipps University Marburg | 2011-04-01 |
| Axitinib as Second-line Treatment for Advanced Hepatocellular Carcinoma (NCT01273662) | National Taiwan University Hospital | 2011-04-01 |
| Effectiveness of Microwave Ablation of Hepatocellular Carcinoma as Compared to Radiofrequency Ablation (NCT01340105) | Chinese University of Hong Kong | 2011-04-01 |
| Stiffness Measurement of Liver Tumors and Visceral Parenchyma (NCT01343212) | China Medical University Hospital | 2011-03-01 |
| An Analysis of Urinary Proteases as Biomarkers for Hepatocellular Carcinoma-101423 (NCT01316679) | Vanderbilt University Medical Center | 2011-03-01 |
| Radiofrequency Ablation Combined With Transcatheter Arterial Chemoembolization Versus Radiofrequency Ablation Alone for Recurrent Hepatocellular Carcinoma (NCT01415063) | Sun Yat-sen University | 2011-02-01 |
| Entecavir for Chronic Hepatitis B in Hepatocellular Carcinoma Patients Underwent Radiofrequency Ablation Therapy (NCT01270178) | Taipei Veterans General Hospital, Taiwan | 2011-01-01 |
| Dynamic Contrast-enhanced Magnetic Resonance Imaging in Evaluation of Liver Functional Status and Treatment Efficacy in Patients With Hepatocellular Carcinoma After Locoregional Therapy (NCT01281683) | National Taiwan University Hospital | 2011-01-01 |
| Observational Study on Patients With Hepatocellular Carcinoma (HCC) (NCT04021056) | Nanfang Hospital, Southern Medical University | 2011-01-01 |
| Palliative Treatments for Patients With Advanced Hepatocellular Carcinoma (HCC) (NCT01409499) | Sun Yat-sen University | 2011-01-01 |
| Comparison of Two Solvents Used With Chemotherapy Agent for Transarterial Chemoembolization of Hepatocellular Carcinoma (NCT01259414) | Sun Yat-sen University | 2011-01-01 |
| A Simple Prognostic Scoring System for Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma (NCT02061956) | Sun Yat-sen University | 2011-01-01 |
| Study of Axitinib in Patients With Unresectable Hepatocellular Carcinoma (NCT01334112) | University Health Network, Toronto | 2011-01-01 |
| Study of Bavituximab and Sorafenib In Patients With Advanced Liver Cancer (NCT01264705) | University of Texas Southwestern Medical Center | 2011-01-01 |
| Axitinib For The Treatment Of Advanced Hepatocellular Carcinoma (NCT01210495) | Pfizer | 2010-12-06 |
| Evaluating the Safety and Efficacy of SB Injection in Patients With Advanced or Primary Hepatocellular Carcinoma (HCC) (NCT01308645) | SBPharmaceutical IND, Co., LTD | 2010-12-01 |
| Sorafenib Dose Ramp-Up in Hepatocellular Carcinoma (HCC) (NCT01203787) | University of Florida | 2010-12-01 |
| Orantinib In Combination With Transcatheter Arterial Chemoembolization In Patients With Unresectable Hepatocellular Carcinoma (NCT01465464) | Taiho Pharmaceutical Co., Ltd. | 2010-12-01 |
| Sorafenib and Micro-therapy Guided by Primovist Enhanced MRI in Patients With Inoperable Liver Cancer (NCT01126645) | University of Magdeburg | 2010-12-01 |
| PET Scan as a Screening Tool for Liver Transplant in Patients With Hepatocellular Carcinoma (HCC) (NCT01320852) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2010-12-01 |
| A Study of Ramucirumab (IMC-1121B) Drug Product (DP) and Best Supportive Care (BSC) Versus Placebo and BSC as 2nd-Line Treatment in Participants With Hepatocellular Carcinoma After 1st-Line Therapy With Sorafenib (NCT01140347) | Eli Lilly and Company | 2010-10-01 |
| Transcatheter Arterial Chemoembolization Therapy In Combination With Sorafenib (NCT01217034) | Kindai University | 2010-10-01 |
| Clinical Study of Sorafenib and Zoledronic Acid to Treat Advanced HCC (NCT01259193) | Fudan University | 2010-10-01 |
| Study of Combined Sorafenib With Radiotherapy in Patients With Advanced Hepatocellular Carcinoma (NCT01328223) | China Medical University Hospital | 2010-09-01 |
| Risk Factors of Hepatocellular Carcinomas Developed on Non-fibrotic Liver: Case-control Study (NoFlic Study) (NCT03852238) | University Hospital, Bordeaux | 2010-08-18 |
| STA-9090 in Patients With Advanced Hepatocellular Cancer (NCT01665937) | Massachusetts General Hospital | 2010-08-01 |
| Hepatocellular Carcinoma - Advanced Stage - Sorafenib Trial in Taiwanese Patients (NCT01098760) | Bayer | 2010-08-01 |
| MRI of the Liver With Eovist (NCT01215838) | University of Washington | 2010-08-01 |
| ABT-888 and Temozolomide for Liver Cancer (NCT01205828) | Georgetown University | 2010-08-01 |
| Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma (NCT01177397) | Celgene | 2010-07-20 |
| Decrease in Circulating Tumour Cell Count Reflects the Effectiveness of Postoperative Adjuvant Transarterial Chemoembolization (TACE) in Preventing Hepatocellular Carcinoma Recurrence (NCT02032368) | Guangdong Provincial People's Hospital | 2010-07-01 |
| Study to Compare Selective Internal Radiation Therapy (SIRT) Versus Sorafenib in Locally Advanced Hepatocellular Carcinoma (HCC) (NCT01135056) | Singapore General Hospital | 2010-07-01 |
| Combined Radiotherapy and Sorafenib in Patients With Hepatoma (NCT01319942) | China Medical University Hospital | 2010-06-01 |
| Safety Study of Liver Natural Killer Cell Therapy for Hepatoma Liver Transplantation (NCT01147380) | Seigo Nishida | 2010-06-01 |
| Changes in Liver Function After Stereotactic Body Radiation Therapy Measured by PET/CT (NCT01213758) | University of Aarhus | 2010-06-01 |
| AFP- L3% and DCP as Tumor Markers in Patients With Hepatocellular Carcinoma (HCC) Treated With Transarterial Chemoembolisation (TACE) (NCT01360255) | University Hospital Freiburg | 2010-05-01 |
| Yttrium-90 Radioembolization With Glass Microspheres (TheraSphere) for Patients With Hepatocellular Carcinoma (NCT01290523) | University of California, San Francisco | 2010-05-01 |
| Efficacy of Sirolimus In Liver Transplantation for Hepatocellular Carcinoma (HCC) (NCT01374750) | Seoul National University Hospital | 2010-05-01 |
| Primary Cell Culture of Hepatic Tumorous Cells From Routine Fine-needle Aspiration (NCT01549275) | Kaohsiung Medical University Chung-Ho Memorial Hospital | 2010-04-01 |
| Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using Transcatheter Arterial Chemoembolization (TACE) With Anti-hepatitis B Virus (Anti-HBV) Therapy (NCT01102335) | Fudan University | 2010-04-01 |
| Study of Pegylated Human Recombinant Arginase for Liver Cancer (BCT-100-002) (NCT01092091) | Bio-Cancer Treatment International Limited | 2010-03-01 |
| Radiofrequency Ablation Versus Hepatic Resection for the Treatment of Hepatocellular Carcinomas Smaller Than 2 cm (NCT01351194) | Sun Yat-sen University | 2010-03-01 |
| Different Genetic Features Associated With Hepatic Carcinogenesis (NCT01247506) | National Taiwan University Hospital | 2010-02-01 |
| Selective Internal Radiation Therapy (SIRT) Versus Transarterial Chemoembolisation (TACE) for the Treatment of Hepatocellular Carcinoma (HCC). (NCT01798160) | Johannes Gutenberg University Mainz | 2010-02-01 |
| Biomarker Analysis in Sorafenib Treated Hepatocellular Carcinoma Patients (NCT01481805) | Samsung Medical Center | 2010-01-14 |
| Sequential Treatment of Hepatocellular Carcinoma by Transarterial Chemoembolization and Local Ablation or External Radiation (NCT04813861) | Central Hospital, Nancy, France | 2010-01-04 |
| Transcatheter Arterial Chemoembolization Combined With Sorafenib for Unresectable Hepatocellular Carcinoma (NCT01833299) | Sun Yat-sen University | 2010-01-01 |
| Role of Choline PET/CT in Predicting Survival in Patients With Hepatocellular Carcinoma (NCT03430635) | Humanitas Clinical and Research Center | 2010-01-01 |
| Clinical Study Examining the Safety and Efficacy of Doxorubicin Drug Eluting Microspheres Transarterial Embolization in the Setting of Hepatocellular Carcinoma (HCC) (NCT01116635) | University of British Columbia | 2010-01-01 |
| Combination Therapy of Microwave Ablation and Cellular Immunotherapy for Hepatocellular Carcinoma (NCT02851784) | Chinese PLA General Hospital | 2009-12-01 |
| Autologous Immune Killer Cells to Treat Liver Cancer Patients as an Adjunct Therapy (NCT03592706) | Ivy Life Sciences, Co., Ltd | 2009-12-01 |
| A Trial of EVL\GVS Alone vs. EVL\GVS Combined Propranolol (S-HCC) (NCT01451658) | Taipei Veterans General Hospital, Taiwan | 2009-12-01 |
| Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma (NCT01008917) | University of California, San Francisco | 2009-11-17 |
| Stereotactic Radiation Therapy and Sorafenib in the Treatment of Hepatocellular Carcinoma (NCT01005875) | University of Alabama at Birmingham | 2009-11-01 |
| Prospective Liver Tumor (ProLiT) Database (NCT01607788) | University of Geneva, Switzerland | 2009-11-01 |